Highest development stage: Phase 2

Development active

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniaeand for the treatment of asymptomatic carriers of Neisseria meningitidis.

Additional information: Semisynthetic sancycline derivative